These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 25460835)

  • 1. Recognition and response to electronic fetal heart rate patterns: impact on newborn outcomes and primary cesarean delivery rate in women undergoing induction of labor.
    Clark SL; Meyers JA; Frye DK; Garthwaite T; Lee AJ; Perlin JB
    Am J Obstet Gynecol; 2015 Apr; 212(4):494.e1-6. PubMed ID: 25460835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing neonatal morbidity by discontinuing oxytocin during the active phase of first stage of labor: a multicenter randomized controlled trial STOPOXY.
    Girault A; Goffinet F; Le Ray C;
    BMC Pregnancy Childbirth; 2020 Oct; 20(1):640. PubMed ID: 33081758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central fetal monitoring: effect on perinatal outcomes and cesarean section rate.
    Withiam-Leitch M; Shelton J; Fleming E
    Birth; 2006 Dec; 33(4):284-8. PubMed ID: 17150066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative efficacy and safety of vaginal misoprostol versus dinoprostone vaginal insert in labor induction at term: a randomized trial.
    Ozkan S; Calişkan E; Doğer E; Yücesoy I; Ozeren S; Vural B
    Arch Gynecol Obstet; 2009 Jul; 280(1):19-24. PubMed ID: 19034471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tachysystole and risk of cesarean section after labor induction using misoprostol: A cohort study.
    Sichitiu J; Vial Y; Panchaud A; Baud D; Desseauve D
    Eur J Obstet Gynecol Reprod Biol; 2020 Jun; 249():54-58. PubMed ID: 32361173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tachysystole in term labor: incidence, risk factors, outcomes, and effect on fetal heart tracings.
    Heuser CC; Knight S; Esplin MS; Eller AG; Holmgren CM; Manuck TA; Richards D; Henry E; Jackson GM
    Am J Obstet Gynecol; 2013 Jul; 209(1):32.e1-6. PubMed ID: 23571133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Induction with Misoprostol Impact the Small for Gestational Age Neonate?
    Foeller ME; Cruz MO; Kominiarek MA; Hibbard JU
    Am J Perinatol; 2015 Dec; 32(14):1311-7. PubMed ID: 26352682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of labor with misoprostol in pregnancies with advanced maternal age.
    Zeteroglu S; Sahin GH; Sahin HA
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):140-4. PubMed ID: 16406221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal and neonatal outcomes associated with induction of labor after one previous cesarean delivery: A French retrospective study.
    Vecchioli E; Cordier AG; Chantry A; Benachi A; Monier I
    PLoS One; 2020; 15(8):e0237132. PubMed ID: 32764773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of obstetrical outcomes with labor induction agents used at term.
    Aghideh FK; Mullin PM; Ingles S; Ouzounian JG; Opper N; Wilson ML; Miller DA; Lee RH
    J Matern Fetal Neonatal Med; 2014 Apr; 27(6):592-6. PubMed ID: 23919802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of a conservative checklist-based protocol for oxytocin administration: maternal and newborn outcomes.
    Clark S; Belfort M; Saade G; Hankins G; Miller D; Frye D; Meyers J
    Am J Obstet Gynecol; 2007 Nov; 197(5):480.e1-5. PubMed ID: 17980181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unintended clinical consequences of the implementation of a checklist-based, low-dose oxytocin protocol.
    Rohn AE; Bastek JA; Sammel MD; Wang E; Srinivas SK
    Am J Perinatol; 2015 Mar; 32(4):371-8. PubMed ID: 25217735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxytocin discontinuation after the active phase of labor is established.
    Vlachos DE; Pergialiotis V; Papantoniou N; Trompoukis S; Vlachos GD
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1421-7. PubMed ID: 25142107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Misoprostol 50 microg sublingually versus vaginally for labor induction at term: a randomized study.
    Caliskan E; Bodur H; Ozeren S; Corakci A; Ozkan S; Yucesoy I
    Gynecol Obstet Invest; 2005; 59(3):155-61. PubMed ID: 15640607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation versus discontinuation of oxytocin infusion during the active phase of labour: a randomised controlled trial.
    Bor P; Ledertoug S; Boie S; Knoblauch NO; Stornes I
    BJOG; 2016 Jan; 123(1):129-35. PubMed ID: 26309128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial.
    Wei RM; Bounthavong M; Hill MG
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100627. PubMed ID: 35358738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CONDISOX- continued versus discontinued oxytocin stimulation of induced labour in a double-blind randomised controlled trial.
    Boie S; Glavind J; Uldbjerg N; Bakker JJH; van der Post JAM; Steer PJ; Bor P
    BMC Pregnancy Childbirth; 2019 Sep; 19(1):320. PubMed ID: 31477047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective randomized study comparing misoprostol and oxytocin for premature rupture of membranes at term.
    Zeteroğlu S; Engin-Ustün Y; Ustün Y; Güvercinçi M; Sahin G; Kamaci M
    J Matern Fetal Neonatal Med; 2006 May; 19(5):283-7. PubMed ID: 16753768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of uterine tachysystole in women induced with oxytocin.
    Kunz MK; Loftus RJ; Nichols AA
    J Obstet Gynecol Neonatal Nurs; 2013; 42(1):12-8. PubMed ID: 23181343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discontinuation of oxytocin in the active phase of labor.
    Girard B; Vardon D; Creveuil C; Herlicoviez M; Dreyfus M
    Acta Obstet Gynecol Scand; 2009; 88(2):172-7. PubMed ID: 19169930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.